Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2023-10-03 00:00:00 ET · period of report 2023-10-02 · accession 0001662579-23-000109 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-03 | 2023-10-02 | CCCC | Anderson Kenneth Carl | Dir | A - Grant | $1.70 | +6,617 | 109.2K | +6% | +$11.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-02 | A | A | 6,617 | $1.70 | 109,237 | D | — | — | (F2) The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 2, 2023. |